Clinical Trials Browser

Phase 1 × apatorsen × Tumor-Agnostic × Clear all

NCT00487786 2016-01-18

Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer

Phase 1 Completed

Neoplasms